ArticleOncotarget2016

Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients.

Hung-Chih Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.